Details - Clinical Research

Clinical Research Details

Back to List

Descriptive Information

Title

The Role of Angiotensin Converting Enzyme Insertion/Deletion Genetic Polymorphism in the Risk, Severity and Prognosis of COVID-19 infection

Investigator Name

Nathalie Khoueiry-Zgheib

nk16@aub.edu.lb

Protocol Id

BIO-2020-0259

Status

Recruiting

Study Type

Observational A clinical study in which participants identified as belonging to study groups are assessed for biomedical or health outcomes. Participants may receive diagnostic, therapeutic, or other types of interventions, but the investigator does not assign participants to specific interventions (as in an interventional study).

Phase

Looking for Med Students Volunteers

Collaborators

Imad Bou Akl
Rami Mahfouz

Sponsors

CNRS-L

Conditions and Keywords

Conditions

covid-19

Keywords

CODI-19 ,Pharmacogenetics,ACE

Study Design

Primary Purpose

Basic / Translational

Classification

N/A: Not Applicable

Time Perspective

Cross-Sectional

Masking

N/A: Not Applicable

Intervention Model

N/A: Not Applicable

Allocation

N/A: Not Applicable

Observational Study Model

Case Control

Eligibility and IRB

Gender

Both

Age Limits

Min: 18

Max: 100

IRB Approval

Yes

Healthy Volunteer

Yes

Study Description

The objectives of this study are to determine whether the ACE I/D genetic polymorphism can be used as a marker for risk, severity and prognosis of COVID-19 infections. It is plausible that subjects carrying the ACE I allele are at a higher risk of infection and worse disease presentation and prognosis.

Population Description

Any subject who presents (or has previously presented) to AUBMC for COVID-19 testing is a potential recruit to the study irrespective of the test result and whether the subject was seen as in- or out-patient.

Sampling Method

Inclusion Criteria

Exclusion Criteria

Back to List